Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells

Toxicology in Vitro

Volumn 24, Issue 4, 2010, Pages 1133-1138

  Meamar, Rokhsareh ^a,b   Karamali, Fereshteh ^a   Sadeghi, Hamid Mirmohamad ^b   Etebari, Mahmood ^b   Nasr Esfahani, Mohammad Hossein ^a   Baharvand, Hossein ^a,c  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF ISFAHAN   (Iran)

^c UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Cardiomyocyte differentiation; Ecstasy; Embryonic stem cells; MDMA; Neuronal differentiation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; MICROTUBULE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO (ANATOMY); EMBRYOID BODY; EMBRYONIC STEM CELL; EMBRYOTOXICITY; HEART MUSCLE CELL; IN VITRO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; TERATOGENICITY;

ANIMALS; CARDIOTOXINS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; FETUS; HALLUCINOGENS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; NEUROTOXINS; STREET DRUGS; TOXICITY TESTS;

EID: 77952955639     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.03.005     Document Type: Article

References (47)

1. Badon L.A., Hicks A., Lord K., Ogden B.A., Meleg-Smith S., Varner K.J. Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of ecstasy. J. Pharmacol. Exp. Ther. 2002, 302:898-907.
2. Baharvand H., Matthaei K.I. Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains. In Vitro Cell Dev. Biol. Anim. 2004, 40:76-81.
3. Baharvand H., Azarnia M., Parivar K., Ashtiani S.K. The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J. Mol. Cell Cardiol. 2005, 38:495-503.
4. Bain G., Kitchens D., Yao M., Huettner J.E., Gottlieb D.I. Embryonic stem cells express neuronal properties in vitro. Dev. Biol. 1995, 168:342-357.
5. Bexis S., Docherty J.R. Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors. Br. J. Pharmacol. 2006, 147:926-934.
6. Bowyer J.F., Young J.F., Slikker W., Itzak Y., Mayorga A.J., Newport G.D., Ali S.F., Frederick D.L., Paule M.G. Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3, 4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. Neurotoxicology 2003, 24:379-390.
7. Buesen R., Visan A., Genschow E., Slawik B., Spielmann H., Seiler A. Trends in improving the embryonic stem cell test (EST): an overview. Altex 2004, 21:15-22.
8. Buesen, R., Genschow, E., Slawik, B., Visan, A., Spielmann, H., Luch, A., Seiler, A., 2009. Embryonic stem cell test (EST) remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol. Sci.
9. Capela J.P., Fernandes E., Remiao F., Bastos M.L., Meisel A., Carvalho F. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology 2007, 28:868-875.
10. Capela J.P., Carmo H., Remiao F., Bastos M.L., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 2009, 39:210-271.
11. Cerretani D., Riezzo I., Fiaschi A.I., Centini F., Giorgi G., D'errico S., Fiore C., Karch S.B., Neri M., Pomara C., Turillazzi E., Fineschi V. Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model. Int. J. Legal Med. 2008, 122:461-469.
12. Colado M.I., O'shea E., Granados R., Misra A., Murray T.K., Green A.R. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br. J. Pharmacol. 1997, 121:827-833.
13. Colado M.I., Camarero J., Mechan A.O., Sanchez V., Esteban B., Elliott J.M., Green A.R. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Br. J. Pharmacol. 2001, 134:1711-1723.
14. De Smedt A., Steemans M., De Boeck M., Peters A.K., Van Der Leede B.J., Van Goethem F., Lampo A., Vanparys P. Optimisation of the cell cultivation methods in the embryonic stem cell test results in an increased differentiation potential of the cells into strong beating myocard cells. Toxicol. In Vitro 2008, 22:1789-1796.
15. Farokhpour M., Karbalaie K., Tanhaei S., Nematollahi M., Etebari M., Sadeghi H.M., Nasr-Esfahani M.H., Baharvand H. Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity. Toxicol. In Vitro 2009, 23:1422-1428.
16. Flicka B., Barenys M., Lapuenteb J., Kluga S., Llobet J. MDMA (ecstasy) and pCPA (para-chlorophenylalanine) effects on embryo development assessed with whole embryo culture (WEC). Abstracts/Reprod. Toxicol. 2009, 28:125-138.
17. Genschow E., Spielmann H., Scholz G., Pohl I., Seiler A., Clemann N., Bremer S., Becker K. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab Anim. 2004, 32:209-244.
18. Green A.R., Mechan A.O., Elliott J.M., O'shea E., Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, " ecstasy" ). Pharmacol. Rev. 2003, 55:463-508.
19. Hatzidimitriou G., Mccann U.D., Ricaurte G.A. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J. Neurosci. 1999, 19:5096-5107.
20. Hernandez-Rabaza V., Dominguez-Escriba L., Barcia J.A., Rosel J.F., Romero F.J., Garcia-Verdugo J.M., Canales J.J. Binge administration of 3,4-methylenedioxymethamphetamine (" ecstasy" ) impairs the survival of neural precursors in adult rat dentate gyrus. Neuropharmacology 2006, 51:967-973.
21. Ho Y.J., Pawlak C.R., Guo L., Schwarting R.K. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav. Brain Res. 2004, 149:135-144.
22. Jimenez A., Jorda E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., Escubedo E., Camarasa J., Camins A., Pallas M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 2004, 196:223-234.
23. Kermani S., Karbalaie K., Madani S.H., Jahangirnejad A.A., Eslaminejad M.B., Nasr-Esfahani M.H., Baharvand H. Effect of lead on proliferation and neural differentiation of mouse bone marrow-mesenchymal stem cells. Toxicol. In Vitro 2008, 22:995-1001.
24. Kindlundh-Hogberg, A.M., Pickering, C., Wicher, G., Hober, D., Schioth, H.B., Fex Svenningsen, A., 2009. MDMA (ecstasy) decreases the number of neurons and stem cells in embryonic cortical cultures. Cell Mol. Neurobiol.
25. Kiuru M., Boyer J.L., O'connor T.P., Crystal R.G. Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell 2009, 4:289-300.
26. Kolbrich E.A., Goodwin R.S., Gorelick D.A., Hayes R.J., Stein E.A., Huestis M.A. Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. J. Clin. Psychopharmacol. 2008, 28:432-440.
27. Lester S.J., Baggott M., Welm S., Schiller N.B., Jones R.T., Foster E., Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann. Intern. Med. 2000, 133:969-973.
28. Mccann U.D., Szabo Z., Scheffel U., Dannals R.F., Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA (" ecstasy" ) on brain serotonin neurons in human beings. Lancet 1998, 352:1433-1437.
29. Meyer J.S., Grande M., Johnson K., Ali S.F. Neurotoxic effects of MDMA (" ecstasy" ) administration to neonatal rats. Int. J. Dev. Neurosci. 2004, 22:261-271.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65:55-63.
31. O'cain P.A., Hletko S.B., Ogden B.A., Varner K.J. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol. Behav. 2000, 70:141-148.
32. Paquette J.A., Kumpf S.W., Streck R.D., Thomson J.J., Chapin R.E., Stedman D.B. Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Res. B Dev. Reprod. Toxicol. 2008, 83:104-111.
33. Putzke J., Spina M.G., Buchler J., Kovar K.A., Wolf G., Smalla K.H. The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain. Addict. Biol. 2007, 12:69-80.
34. Rohwedel J., Guan K., Hegert C., Wobus A.M. Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects. Toxicol. In Vitro 2001, 15:741-753.
35. Sagha M., Karbalaie K., Tanhaee S., Esfandiari E., Salehi H., Sadeghi-Aliabadi H., Razavi S., Nasr-Esfahani M.H., Baharvand H. Neural induction in mouse embryonic stem cells by co-culturing with chicken somites. Stem Cells Dev. 2009, 18:1351-1360.
36. Saretzki G., Armstrong L., Leake A., Lako M., Von Zglinicki T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem cells 2004, 22:962-971.
37. Sauer H., Gunther J., Hescheler J., Wartenberg M. Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am. J. Pathol. 2000, 156:151-158.
38. Scholz G., Pohl I., Genschow E., Klemm M., Spielmann H. Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 1999, 165:203-211.
39. Seiler A., Visan A., Buesen R., Genschow E., Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol. 2004, 18:231-240.
40. Simantov R. Multiple molecular and neuropharmacological effects of MDMA (ecstasy). Life Sci. 2004, 74:803-814.
41. Steven B.K. Hallucinogens. Karch's Pathology of Drug Abuse 2001, CRC Press, Michigan, pp. 281-300.
42. Stumm G., Schlegel J., Schafer T., Wurz C., Mennel H.D., Krieg J.C., Vedder H. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 1999, 13:1065-1072.
43. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
44. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
45. Whitlow S., Burgin H., Clemann N. The embryonic stem cell test for the early selection of pharmaceutical compounds. Altex 2007, 24:3-7.
46. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin Ii., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
47. Zur Nieden N.I., Kempka G., Ahr H.J. Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol. 2004, 194:257-269.